These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23297508)

  • 1. [Croatian Society for Haematology and Transfusion Medicine Guidelines on the diagnosis and management of heparin induced thrombocytopenia (HIT)].
    Bosnjak B; Culjak-Aleksić M; Gojceta K; Golubić-Cepulić B; Debeljak Z; Dodig J; Kogler-Majerić V; Mesarić J; Peraica-Planinc A; Princić M; Rode B; Skorić B; Stancic V; Suvić-Krizanić V; Sturm D; Tomicić M;
    Lijec Vjesn; 2012; 134(9-10):253-8. PubMed ID: 23297508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-induced thrombocytopenia: natural history, diagnosis, and management.
    Deitcher SR; Carman TL
    Vasc Med; 2001; 6(2):113-9. PubMed ID: 11530963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of heparin-induced thrombocytopenia].
    Aouizerate P; Guizard M
    Therapie; 2002; 57(6):577-88. PubMed ID: 12666266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-induced thrombocytopenia: diagnosis and management.
    Liebman HA
    Vascular; 2008; 16 Suppl 1():S71-6. PubMed ID: 18544310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The identification and management of heparin-induced thrombocytopenia in the vascular patient.
    LaMuraglia GM; Houbballah R; Laposata M
    J Vasc Surg; 2012 Feb; 55(2):562-70. PubMed ID: 22188737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-induced thrombocytopenia: an update.
    Prechel M; Walenga JM
    Semin Thromb Hemost; 2012 Jul; 38(5):483-96. PubMed ID: 22399304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-induced thrombocytopenia: clinical manifestations and management strategies.
    Menajovsky LB
    Am J Med; 2005 Aug; 118 Suppl 8A():21S-30S. PubMed ID: 16125511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The heparin-induced thrombocytopenia task force model: implementing quality improvement and economic outcome initiatives.
    Frame JN
    Semin Hematol; 2005 Jul; 42(3 Suppl 3):S28-35. PubMed ID: 16105556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heparin induced thrombocytopenia].
    Králová S; Klodová D; Gumulec J; Novotný J; Klaricová K; Wróbel M; Brejcha M; Sumná E
    Vnitr Lek; 2006 Mar; 52 Suppl 1():98-106. PubMed ID: 16637457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of suspected heparin-induced thrombocytopenia in US hospitals.
    Multz AS; Lisker GN
    Clin Appl Thromb Hemost; 2014 Jan; 20(1):68-72. PubMed ID: 22892988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin induced thrombocytopenia: diagnosis and management.
    Alaraj A; Wallace A; Tesoro E; Ruland S; Amin-Hanjani S; Charbel FT; Aletich V
    J Neurointerv Surg; 2010 Dec; 2(4):371-8. PubMed ID: 21990651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
    Demma LJ; Winkler AM; Levy JH
    Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heparin-induced thrombocytopenia: implictions for cardiologist].
    Mattioli AV
    G Ital Cardiol (Rome); 2006 Oct; 7(10):675-83. PubMed ID: 17171989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.
    Legnani C; Cini M; Pili C; Boggian O; Frascaro M; Palareti G
    Thromb Haemost; 2010 Aug; 104(2):402-9. PubMed ID: 20539902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The management of patients with heparin-induced thrombocytopenia].
    Pötzsch B; Madlener K
    Hamostaseologie; 2006 Jan; 26(1):22-6. PubMed ID: 16444318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-induced thrombocytopenia: current status and diagnostic challenges.
    Otis SA; Zehnder JL
    Am J Hematol; 2010 Sep; 85(9):700-6. PubMed ID: 20665476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Heparin-induced thrombocytopenia].
    Gruel Y; Regina S; Pouplard C
    Rev Prat; 2006 Apr; 56(7):710-8. PubMed ID: 16739902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-induced thrombocytopenia: diagnosis and management.
    Hassell K
    Thromb Res; 2008; 123 Suppl 1():S16-21. PubMed ID: 18829068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
    Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
    Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory tests for the diagnosis of heparin-induced thrombocytopenia.
    Walenga JM; Jeske WP; Fasanella AR; Wood JJ; Bakhos M
    Semin Thromb Hemost; 1999; 25 Suppl 1():43-9. PubMed ID: 10357151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.